COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be presented at AACR
ProteinQure announces breakthrough in triple-negative breast cancer treatment through novel Peptide Drug Conjugate with exceptional efficacy in lab experiments -
-
-
-
COMMUNIQUÉ DE PRESSE
Sinopec FY2023 Annual Results
Sinopec Corp. achieved solid 2023 operating results with revenue at RMB 3.21 trillion. Focus on shareholder returns, dividend payout exceeds 70%. Board proposed final cash dividend of RMB0.2 per share. Production records in oil, gas, and refined products -
COMMUNIQUÉ DE PRESSE
Calling all Music Fans - Be Part of the Iconic Coachella Music Festival! Allied Universal Hiring For Coachella Valley Music and Arts Festival
Allied Universal® is seeking event staff and security positions for Coachella, offering competitive pay, flexible schedules, and career advancement opportunities. Apply online now! -
COMMUNIQUÉ DE PRESSE
Temas Resources Revised Terms of Previous Announced Non-Brokered Private Placement of up to $1.5 Million
Temas Resources Corp. announces amended terms for non-brokered private placement, reducing price per unit to $0.20. Proceeds to advance La Blache project and for working capital -
COMMUNIQUÉ DE PRESSE
Digital World Acquisition Corp. Stockholders Approve the Proposed Merger With Trump Media & Technology Group Corp.
Digital World Acquisition Corp. announced stockholder approval for the merger with Trump Media & Technology Group Corp., aiming to trade on Nasdaq under 'DJT' & 'DJTWW'. CEO Eric Swider & TMTG CEO Devin Nunes comment on the anticipated merger -
COMMUNIQUÉ DE PRESSE
Amid FDA Concerns of Chinese Supplied Needles & Syringes, HTL-Strefa Inc. Offers a Reliable and Safe Alternative With Its European-Produced Passive Safety Needle, Sicura TM
HTL-Strefa Inc. introduces DropSafe® Sicura™, the first fully passive safety needle in North America, offering a safe injection experience. FDA-cleared and European-made, it aligns with top patient care standards
